Institutional Clinical and Translational Science Award

机构临床和转化科学奖

• 批准号: 9261656
• 负责人: GARRET A FITZGERALD
• 金额: $ 998.54万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-07-01 至 2021-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9261656
• 关键词: Academia; Adult; Area; Award; Biological Models; Biotechnology; Cell model; Center for Translational Science Activities; Chemicals; Childhood; Clinical; Clinical Research; Clinical Sciences; Clinical and Translational Science Awards; Congresses; Development; Devices; Discipline; Disease; Dose; Drug Approval; Drug Exposure; Drug effect disorder; Educational process of instructing; Evolution; Faculty; Fostering; Functional disorder; Funding; Geography; Growth; Home environment; Human; Institutes; Institution; Longevity; Marketing; Measures; Mission; Modeling; Pediatric Hospitals; Pennsylvania; Pharmaceutical Preparations; Pharmacologic Substance; Phenotype; Philadelphia; Physiological; Physiology; Population; Private Sector; Process; Research; Research Personnel; Resources; Safety; Schools; Science; Signal Transduction; Staging; The Wistar Institute; Therapeutic; Time; Transcend; Translational Research; Translations; United States National Institutes of Health; Universities; Vision; abstracting; clinical investigation; interest; medical schools; novel; novel therapeutics; pre-clinical; precision medicine; programs; response; translational medicine

Contact PD/PI: FITZGERALD, GARRET A OVERALL ABSTRACT/SUMMARY The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in Penn. For the past decade the specific aims of ITMAT have been and remain (i) to increase the number of investigators capable of pursuing their research between proof of concept in cells and model systems and (ii) elucidation of the mechanisms of human physiology, disease or drug action through intense phenotyping in small numbers of people. The two priorities of our CTSA are to foster the field of translational therapeutics and to bridge the pediatric to adult divide across the entire spectrum of clinical and translational science. This section describes how these priorities have influenced the growth of this CTSA Hub and outlines our plans for the coming funding period. Project Summary/Abstract Page 103 Contact PD/PI: FITZGERALD, GARRET A OVERALL NARRATIVE The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in Penn. For the past decade the specific aims of ITMAT have been and remain (i) to increase the number of investigators capable of pursuing their research between proof of concept in cells and model systems and (ii) elucidation of the mechanisms of human physiology, disease or drug action through intense phenotyping in small numbers of people.

联系PD/PI：Fitzgerald，Garret A 总体来说 摘要/摘要 转化医学和治疗研究所是CTSA#年的学术中心 宾夕法尼亚。在过去的十年中，ITMAT的具体目标一直是并将继续：(一)增加 能够在细胞中的概念证明之间进行研究的研究人员的数量 和模型系统，以及(Ii)阐明人类生理、疾病或 在少数人中通过强烈的表型来发挥药物作用。我们的两个优先事项 CTSA将促进翻译治疗领域的发展，并在儿童和成人之间架起一座桥梁 横跨临床和转化科学的整个范围。本部分介绍 这些优先事项如何影响了CTSA枢纽的发展，并概述了我们的 即将到来的资金期。 项目摘要/摘要页103 联系PD/PI：Fitzgerald，Garret A 总体来说 叙事 转化医学和治疗研究所是CTSA#年的学术中心 宾夕法尼亚。在过去的十年中，ITMAT的具体目标一直是并将继续：(一)增加 能够在细胞中的概念证明之间进行研究的研究人员的数量 和模型系统，以及(Ii)阐明人类生理、疾病或 在少数人中通过强烈的表型来发挥药物作用。